Representatives from Merck Pharmaceuticals appeared before a FDA committee on November 13, 1997 to present their clinical trial data in order to get FDA approval.

The FDA committee, consisting of many doctors, questioned Merck on several issues. Many of these same questions are asked by Propecia users and prospective users today. Unfortunately some doctors just don't have all the answers and are not well read on the various issues and concerns of users.

We have obtained the FDA committee transcripts and are providing them on the site so you can get answers to many of the questions you may have. What makes these transcripts invaluable is that the answers are coming directly from the people who conducted the Propecia trials. In addition the answers are very thorough and often contain information not readily available.

We are breaking down the questions into various topics for ease of use and will be adding to them in the next few weeks. The original document is several hundred pages long and can be download here in PDF or RTF format if you prefer.

(Please note that the excerpts don't always follow the exact sequence the questions were originally presented in)